Phase I and pharmacokinetic study of tiazofurin (NSC 286193) administered by 5-day continuous infusion
- 1 March 1986
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 16 (2) , 160-164
- https://doi.org/10.1007/bf00256168
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- ACTIVITY AND METABOLISM OF 2-BETA-D-RIBOFURANOSYLTHIAZOLE-4-CARBOXAMIDE IN HUMAN LYMPHOID TUMOR-CELLS IN CULTURE1983
- Studies on the mechanism of action of 2-β-d-ribofuranosylthiazole-4-carboxamide (NSC 286193)-IIBiochemical Pharmacology, 1982
- Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-β-d-ribofuranosylthiazole-4-carboxamide NSC 286193)Biochemical Pharmacology, 1982
- The conversion of 2-β-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory propertiesBiochemical Pharmacology, 1982
- 2-.beta.-D-ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastasesJournal of Medicinal Chemistry, 1982
- Reporting results of cancer treatmentCancer, 1981
- A comparison of 5-fluorouracil administered by slow infusion and rapid injection.1972
- Design, synthesis, and broad spectrum antiviral activity of 1-.beta.-D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosidesJournal of Medicinal Chemistry, 1972
- REDUCTION OF 5-FLUOROURACIL TOXICITY IN MAN WITH RETENTION OF ANTICANCER EFFECTS BY PROLONGED INTRAVENOUS ADMINISTRATION IN 5-PERCENT DEXTROSE1960
- STUDIES OF THE URICOGENIC EFFECT OF 2-SUBSTITUTED THIADIAZOLES IN MAN*Journal of Clinical Investigation, 1959